Skip to main content

Williamson Stephen's Form 4 filing

Thermo Fisher Scientific Inc. (TMO) · filed May 15, 2024

Accession no.
0001127602-24-015442
Filed
May 15, 2024
Trade date
May 13-14, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $13.0M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Williamson StephenCIK 0001648929Officer (Sr. VP and CFO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 13, 2024Common StockMOption exerciseAcquired+21,925$210.68+$4,619,15958,406.99Direct
May 13, 2024Common StockSSaleDisposed−21,925$591.27−$12,963,594.7536,481.99Direct
May 14, 2024Common StockGGiftDisposed−3,297$0.00$033,184.99Direct
May 14, 2024Common StockGGiftDisposed−12,674$0.00$020,510.99Direct
May 14, 2024Common StockGGiftAcquired+12,674$0.00$012,674Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 13, 2024Common StockMOption exerciseDisposed−21,925$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)